JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Aerospace, Aviation & Defense Market Research Reports

To refine your search by industry, market, geographic region, country or price, use Advanced Search or contact Client Services for assistance.

1
2
3
4
5

Report Title

Published

Price

2023 Leading Aerospace, Aviation and Defense Companies Capabilities, Goals and Strategies

August 1, 2023

$2,450.00
Military Helicopter Market Report 2023-2033

May 22, 2023

$4,938.00
Military GPS and GNSS Devices Market Report 2023-2033

May 15, 2023

$4,938.00
Military Communications & COTS Market Report 2023-2033

April 6, 2023

$4,938.00
Aviation Maintenance, Repair & Overhaul (MRO) Market Report 2023-2033

March 30, 2023

$4,938.00
Aerospace Robotics Market Report 2023-2033

March 28, 2023

$4,938.00
Civil Aviation Flight Simulation & Simulation Training Market Report 2023-2033

March 20, 2023

$4,938.00
Hydrogen Aircraft Market Report 2023-2033

March 8, 2023

$4,938.00
Military Aircraft Maintenance, Repair & Overhaul (MRO) Market Report 2023-2033

February 16, 2023

$4,938.00
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Dengue Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Eastern Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Western Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Familial Amyloid Neuropathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Pituitary ACTH Hypersecretion (Cushing Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00
Prosthetic Joint Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

January 28, 2023

$2,000.00

1
2
3
4
5